Skip to main content

Table 2 Association of secondhand smoke exposure with cardiometabolic health among never-smoking adult cancer survivors in the Korea National Health and Nutrition Examination Survey, 2013–2018

From: Association of secondhand smoke exposure with cardiometabolic health in never-smoking adult cancer survivors: a population-based cross-sectional study

  No Secondhand Smoke Exposure in Never-Smoking Adult Cancer Survivors
(N = 591)
Secondhand
Smoke Exposure in Never-Smoking Adult Cancer Survivors
(N = 239)
Hypertension (2017 AHA/ACCa)
 Model 1 1.00 (Ref) 1.29 (0.88–1.89)
 Model 2 1.00 (Ref) 1.31 (0.89–1.93)
 Model 3 1.00 (Ref) 1.33 (0.90–1.96)
General obesityb
 Model 1 1.00 (Ref) 1.47 (0.98–2.22)
 Model 2 1.00 (Ref) 1.47 (0.97–2.23)
 Model 3 1.00 (Ref) 1.47 (0.97–2.22)
Abdominal obesityb
 Model 1 1.00 (Ref) 1.20 (0.82–1.75)
 Model 2 1.00 (Ref) 1.19 (0.81–1.74)
 Model 3 1.00 (Ref) 1.20 (0.82–1.75)
Hyperlipidemiac
 Model 1 1.00 (Ref) 0.99 (0.67–1.47)
 Model 2 1.00 (Ref) 1.02 (0.67–1.54)
 Model 3 1.00 (Ref) 1.03 (0.68–1.55)
Hypertriglyceridemiac
 Model 1 1.00 (Ref) 1.63 (1.08–2.46)*
 Model 2 1.00 (Ref) 1.62 (1.06–2.47)*
 Model 3 1.00 (Ref) 1.63 (1.07–2.48)*
Reduced HDL-Cc
 Model 1 1.00 (Ref) 1.04 (0.72–1.49)
 Model 2 1.00 (Ref) 0.99 (0.69–1.43)
 Model 3 1.00 (Ref) 1.01 (0.70–1.45)
Impaired fasting glucose (ADA/WHOd)
 Model 1 1.00 (Ref) 1.07 (0.73–1.58)
 Model 2 1.00 (Ref) 1.06 (0.71–1.57)
 Model 3 1.00 (Ref) 1.07 (0.72–1.58)
  1. Values above are presented as adodds ratios and 95% confidence intervals computed from multiple logistic regression accounting for the sampling weights. Model 1 was adjusted for sociodemographic factors (age, sex, education level, household income, marital status, residential area, occupation type), Model 2 was adjusted for variables included in Model 1 and health behavior (aerobic exercise, muscle strengthening exercise, alcohol consumption, total energy intake), and Model 3 was adjusted for family history of cardiovascular disease (coronary heart disease or stroke) in addition to the variables included in Model 1 and 2
  2. Acronyms: AHA American Heart Association, ACC American College of Cardiology, BMI Body Mass Index, WC Waist Circumference, HDL-C High-Density Lipoprotein Cholesterol, ADA American Diabetes Association, WHO World Health Organization, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, FSG Fasting Serum Glucose
  3. aDefined as SBP ≥ 130 mmHg or DBP ≥ 80 mmHg or taking antihypertensive drugs according to the 2017 AHA/ACC high blood pressure guidelines
  4. bGeneral obesity defined as BMI ≥ 25.0 kg/m2 and abdominal obesity defined as WC ≥ 90 cm for men and WC ≥ 85 cm for women
  5. cHyperlipidemia defined as total cholesterol ≥ 240 mg/dL or taking cholesterol lowering drugs; hypertriglyceridemia defined as triglyceride ≥ 200 mg/dL or taking cholesterol lowering drugs: reduced HDL-C defined as HDL-C ≤ 40 mg/dL for men and HDL-C ≤ 50 mg/dL for women
  6. dDefined as FSG of 110–125 mg/dL according to the ADA and WHO
  7. *p < 0.05